Alternative to Saline Nasal Rinse in Pregnancy
When saline nasal rinse is unavailable, intranasal corticosteroids—specifically budesonide—are the safest and most effective alternative for managing nasal symptoms in pregnant women, with extensive human safety data across all trimesters. 1
First-Line Alternative: Intranasal Corticosteroids
Budesonide nasal spray is the preferred intranasal corticosteroid because it has the most extensive human safety data and is classified as Pregnancy Category B, supported by large-scale safety registries. 1
Intranasal corticosteroids are safe and effective throughout pregnancy, offering superior efficacy with minimal systemic absorption; multiple cohort studies and meta-analyses show no increased risk of major malformations, preterm delivery, low birth weight, or pregnancy-induced hypertension. 1
Other intranasal corticosteroids (beclomethasone, fluticasone propionate, mometasone) have not shown convincing evidence of congenital defects in pregnancy and may be used at recommended therapeutic doses. 1, 2
The minimal systemic absorption of intranasal corticosteroids makes them particularly safe while maintaining local efficacy for nasal congestion and inflammation. 1
Additional Safe Alternatives
Sodium Cromolyn
Sodium cromolyn (Pregnancy Category B) is safe but requires frequent dosing (four times daily) and has limited efficacy compared with intranasal corticosteroids. 1
This option is appropriate for patients preferring a non-steroidal approach, though the dosing frequency may reduce adherence. 1
Oral Antihistamines
Cetirizine and loratadine are the preferred oral antihistamines during pregnancy, supported by robust safety data from large observational cohorts. 1
Second-generation antihistamines provide safety comparable to first-generation agents while avoiding sedative and anticholinergic side effects. 1
Antihistamines are safe and beneficial options for treating pregnancy-induced rhinitis and allergic rhinitis. 3
Mechanical Options
Nasal alar dilators (mechanical nasal strips) are safe means to relieve nasal congestion without any systemic medication exposure. 4
These devices physically open the nasal passages and can be used throughout pregnancy without restriction. 4
Treatment Algorithm by Symptom Severity
Mild Intermittent Symptoms
- Begin with nasal alar dilators or positioning strategies (elevating head during sleep). 1, 4
- Add cetirizine or loratadine if mechanical measures are insufficient. 1
Mild-to-Moderate Persistent Symptoms
- Use intranasal budesonide as first-line therapy. 1
- Add cetirizine or loratadine if response is inadequate. 1
- Consider sodium cromolyn for patients preferring non-steroidal options. 1
Moderate-to-Severe Persistent Symptoms
- Combine intranasal corticosteroid (budesonide preferred) with an oral second-generation antihistamine. 1
Critical Medications to Avoid
Oral decongestants (phenylephrine, pseudoephedrine) should be strictly avoided in the first trimester because of associations with gastroschisis, small-intestinal atresia, and cardiac anomalies. 1, 5, 6
Oral decongestants may also contribute to maternal hypertension and should be avoided throughout pregnancy. 1, 5
Intranasal antihistamines (e.g., azelastine) lack sufficient safety data and should be avoided during pregnancy. 1
First-generation antihistamines are generally avoided because of sedative and anticholinergic effects. 1
Dosing Considerations
Use the lowest effective dose of intranasal corticosteroid to maintain symptom control and limit systemic exposure. 1
Instruct patients on proper nasal spray technique—aiming the spray away from the nasal septum—to minimize local adverse effects such as epistaxis. 1
Common Pitfalls
Do not recommend nasal decongestant sprays (oxymetazoline, phenylephrine) as they tend to be overused, leading to rhinitis medicamentosa. 4
Do not delay effective treatment; untreated nasal congestion can affect sleep quality and overall maternal well-being during pregnancy. 6
Avoid combination products containing decongestants with acetaminophen or salicylates, as these carry higher malformation risks. 1